Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sakulrat Mankhong, Sujin Kim, Seongju Lee, Hyo-Bum Kwak, Dong-Ho Park, Kyung-Lim Joa, Ju-Hee Kang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2022-04-01
Reeks:Biomedicines
Onderwerpen:
Alzheimer’s biomarker
cerebrospinal fluid
blood-based biomarker
clinical trial
amyloid-beta
tau
Online toegang:https://www.mdpi.com/2227-9059/10/4/850
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items